A Study of Patient Preferences and Drivers of Treatment Satisfaction in Patients With Rosacea
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- LEO Pharma
- 入组人数
- 206
- 主要终点
- Self-reported concerns and importance of such concerns regarding their current topical rosacea treatments
研究概览
简要总结
To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female patients of at least 18 years of age at index date
- •At least one prescription for a topical rosacea treatments: Azelaic Acid Gel, Azelaic Acid Cream, Metronidazole Gel, Metronidazole Cream, Metronidazole Emulsion, Metronidazole Lotion, Brimonidine Tartrate Gel
- •At least one medical record with a diagnosis code for rosacea (ICD-9: 695.3)
- •At least 6 months of data history prior to the index date
- •Had at least one encounter at the Reliant Medical Group within 3 months prior to 01 January 2015
排除标准
- 未提供
研究组 & 干预措施
Rosacea treated patients
Patients using topical rosacea treatment
干预措施: Azelaic Acid Cream (Drug)
Rosacea treated patients
Patients using topical rosacea treatment
干预措施: Metronidazole gel (Drug)
Rosacea treated patients
Patients using topical rosacea treatment
干预措施: Metronidazole cream (Drug)
Rosacea treated patients
Patients using topical rosacea treatment
干预措施: Metronidazole Emulsion (Drug)
Rosacea treated patients
Patients using topical rosacea treatment
干预措施: Metronidazole Lotion (Drug)
Rosacea treated patients
Patients using topical rosacea treatment
干预措施: Brimonidine Tartrate Gel (Drug)
结局指标
主要结局
Self-reported concerns and importance of such concerns regarding their current topical rosacea treatments
时间窗: Rosacea treatment in the past 4 weeks
Assessed from the Rosacea Treatment Preference Questionnaire: Rated on a scale of 0 to 10, with 0 meaning not at all important and 10 meaning extremely important
次要结局
- Quality of life(Rosacea treatment in the past 4 weeks)
- Self-reported concerns and importance (a rating scale) of such concerns that patients would consider when switching to a new topical rosacea treatment(Rosacea treatment in the past 4 weeks)
- Self-reported likelihood of switching to a topical rosacea treatments(Rosacea treatment in the past 4 weeks)
- Treatment satisfaction(Rosacea treatment in the past 4 weeks)